GLP-1 Receptor Agonists and Cardiovascular Outcomes

In this free pharmacology continuing education course, Eryn Bryant, RN, MS, ANP discusses the use of GLP-1 Receptor Agonists (GLP-1 RAs) in clinical practice. This CE course describes the cardiovascular and heart failure outcomes associated with this important hormone.

Read More

SGLT2 Inhibitors and Cardiovascular Outcomes

Atherosclerotic Cardiovascular Disease, Heart Failure, and SGLT2 Inhibitors This SGLT2 inhibitor continuing education course provides timely insights into implementing evidence-based treatment strategies related to atherosclerotic cardiovascular disease, heart failure, and SGLT2 inhibitors. Darren McGuire, MD, MHSc summarizes the glycemic and non-glycemic effects of SGLT2 Inhibitors, their safety profile, and covers recent clinical outcome trials. Cindy…

Read More

Making the Link Between Diabetes and Cardiovascular Disease

Learn practical approaches for cardiovascular clinicians to incorporate the treatment of diabetic patients in cardiology practices. Stanford endocrinologist, Dr. Marilyn Tan reviews current clinical practice guidelines and prescribing recommendations for diabetic therapies that have proven CV outcomes. Then learn to apply these recommendations to cardiovascular patient case studies with nurse practitioner Cindy Lamendola.

Read More

Connecting Diabetes and Heart Disease

Achieving Improved Cardiovascular Outcomes in Patients with Diabetes It is important for cardiovascular nurses, nurse practitioners and other members of the cardiovascular health care team to ensure patients with diabetes are effectively treated with evidence-based therapies. By initiating or switching to appropriate treatments for diabetes, improved patient outcomes are possible, with reduced risk of major…

Read More